Keywords: cRGD; brain-targeting drug delivery system; monocyte; depression; trefoil factor 3; cRGD; cyclic RGD; cRGDL; cRGD-modified liposomes; TFF3; trefoil factor 3; cRGDL-TFF3; cRGD liposomes loaded with TFF3; BBB; blood-brain barrier; i.p; intraperitoneal; HBME
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Microenvironment; Mechanobiology; Epithelial-mesenchymal transition; MDCK; cRGD; Extracellular matrix
IR780 based nanomaterials for cancer imaging and photothermal, photodynamic and combinatorial therapies
Keywords: Ce6; chlorin e6; cRGD; cyclic Arg-Gly-Asp; DOX; doxorubicin; ECM; extracellular matrix; EGFR; epidermal growth factor receptor; EPR; enhanced permeation and retention; FDA; food and drug administration; HA; hyaluronic acid; HSA; human serum albumin; ICG;
Synthesis and photodynamic activities of integrin-targeting silicon(IV) phthalocyanine-cRGD conjugates
Keywords: Silicon(IV) phthalocyanine; Integrin; cRGD; Photodynamic therapy; Cancer;
αvβ3 Integrin-targeted reduction-sensitive micellar mertansine prodrug: Superb drug loading, enhanced stability, and effective inhibition of melanoma growth in vivo
Keywords: Mertansine; Prodrug; cRGD; Reduction-responsive; Targeted chemotherapy;
Modulating angiogenesis with integrin-targeted nanomedicines
Keywords: (RGD)m; RGD mimetics; 4-NQO; 4-nitroquinoline 1-oxide; AAA; Abdominal Aortic Aneurysms; ADA; 8-Amino-3,6-Dioxaoctonoic Acid; AH-GDM; Aminohexyl-Geldanamycin; ami; Amide; AP-2α; Activating Protein 2α; ARMS; Alveolar Rhabdomyosarcoma; ATO; Arsenic Trioxid
Iron oxide nanoparticle surface decorated with cRGD peptides for magnetic resonance imaging of brain tumors
Keywords: Glioblastoma; Iron oxide nanoparticle; MRI contrast agent; cRGD; Targeting;
Recent advances in the design, development, and targeting mechanisms of polymeric micelles for delivery of siRNA in cancer therapy
Keywords: AFM; atomic force microscopy; AMD; age-related macular degeneration; ANG; Angiopep-2; apoB; apolipoprotein B; ATP; adenosine triphosphate; AURKA; Aurora A kinase; BMA; butylmethacrylate; BPEI; branched PEI; BSA; bovine serum albumin; CCP; charge-conversio
cRGD-functionalized reduction-sensitive shell-sheddable biodegradable micelles mediate enhanced doxorubicin delivery to human glioma xenografts in vivo
Keywords: cRGD; Reduction-sensitive; Shell-sheddable; Biodegradable micelles; Doxorubicin; Targeted delivery;
Amyloid β induces microglia to phagocytose neurons via activation of protein kinase Cs and NADPH oxidase
Keywords: Aβ; amyloid beta; AEBSF; 4-(2-aminoethyl)-benzenesulfonyl fluoride; cRGD; cyclic peptide arginine-glycine-aspartate-d-phenylalanine-valine; fMLP; N-formylmethionyl-leucyl-phenylalanine; iNOS; inducible NO synthase; LME; l-leucine methyl ester; LPS; lipop
Polycations and their biomedical applications
Keywords: Ac-aCD; acetalated cyclodextrin; ASC; adipose-derived stromal cell; αSMA; α-smooth muscle actin; BMA; butyl methacylate; BMP; bone morphogenetic protein; BSA; bovine serum albumin; CDP; cyclodextrin-containing polymer; CPLA; cationic polylactide; cRGD;
Fabrication and evaluation of tumor-targeted positive MRI contrast agent based on ultrasmall MnO nanoparticles
Keywords: Ultrasmall MnO nanoparticles; Positive contrast agent; cRGD; Magnetic resonance imaging; Longitudinal relaxivity;
Multifunctional drug nanocarriers formed by cRGD-conjugated βCD-PAMAM-PEG for targeted cancer therapy
Keywords: PAMAM dendrimer; β-Cyclodextrin; Drug loading; Targeted delivery; cRGD;
Tumour necrosis factor alpha-induced neuronal loss is mediated by microglial phagocytosis
Keywords: cRGD; cyclic peptide arginine-glycine-aspartate-d-phenylalanine-valine; LPS; lipopolysaccharide; MFG-E8; milk fat globule EGF factor-8; MRS; MRS2578 compound; TNF-α; tumour necrosis factor-α; VNR; vitronectin receptor; Neuroinflammation; Phagopt
cRGD-directed, NIR-responsive and robust AuNR/PEG-PCL hybrid nanoparticles for targeted chemotherapy of glioblastoma in vivo
Keywords: cRGD; Gold nanorods; Biodegradable nanoparticles; Doxorubicin; NIR-sensitive; Glioblastoma;
PET imaging and biodistribution analysis of the effects of succinylated gelatin combined with l-lysine on renal uptake and retention of 64Cu-cyclam-RAFT-c(-RGDfK-)4in vivo
Keywords: PET; positron emission tomography; GF; Gelofusine; Lys; l-lysine; Radio-TLC; radio-thin-layer chromatography; RAFT; Regioselectively Addressable Functionalized Template; cRGD; cyclic pentapeptide containing the tripeptide sequence Arg-Gly-Asp; cyclam; 1,4
cRGD grafted liposomes containing inorganic nano-precipitate complexed siRNA for intracellular delivery in cancer cells
Keywords: Calcium phosphate; cRGD; siRNA; Liposome; Nano-precipitate
MR imaging techniques for nano-pathophysiology and theranostics
Keywords: 3D; three dimensional; C60; fullerene; CEST; chemical exchange saturation transfer; CNT; carbon nanotube; cRGD; cyclic peptide containing an arginine-glycine-aspartic acid sequence; CT; computed tomography; DACHPt; (1,2-diaminocyclohexane)platinum(II)
Cyclic RGDyk-conjugated LMWH-taurocholate derivative as a targeting angiogenesis inhibitor
Keywords: Heparin-taurocholate; LMWH; cRGD; αvβ3 integrin; Angiogenesis inhibitor
Pigment epithelium-derived factor gene loaded in cRGD-PEG-PEI suppresses colorectal cancer growth by targeting endothelial cells
Keywords: PEDF; PEG-PEI; cRGD; HUVECs; Gene therapy;
Cryptic domains of tenascin-C differentially control fibronectin fibrillogenesis
Keywords: cRGD; cyclo (Arg-Gly-Asp-d-Phe-Val); FBG; fibrinogen like globe; TNfn; fibronectin type III modules from tenascin-C; Tenascin-C; Fibrinogen globe; TNfn1-8; Fibronectin; Extracellular matrix; MDCK tubulogenesis;